Literature DB >> 15334687

Low plasma apolipoprotein A-I level is not a reliable marker of fibrosis in children with chronic hepatitis B.

Mukadder-Ayse Selimoglu1, Rasit-Vural Yagcl, Gül Yüce.   

Abstract

AIM: To evaluate the clinical value of plasma apolipoprotein A-I (Apo A-I) as a marker of fibrosis in children with chronic hepatitis B (CHB).
METHODS: Liver biopsy specimens from 49 children with CHB were evaluated by using Knodell index. Plasma Apo A-I level was measured after 12-h fasting. Student's t test, Spearman's correlation test and receptor-operating characteristic (ROC) curve were used for statistical evaluation.
RESULTS: Mean Apo A-I level of the patients was not different from that of controls (P>0.05). Six (8.7%) children had fibrosis score of more than 2 (severe fibrosis). No difference in the level of mean plasma Apo A-I was found among children with and without severe fibrosis (P>0.05). No correlation between Apo A-I level and fibrosis scores was found (P>0.05). The area under the ROC curve was 0.407+/-0.146 (P>0.05).
CONCLUSION: Severe fibrosis is not common in children with CHB and plasma Apo A-I level is not a reliable indicator of fibrosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334687      PMCID: PMC4572119          DOI: 10.3748/wjg.v10.i19.2864

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

Review 1.  Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435].

Authors:  Valeer J Desmet
Journal:  J Hepatol       Date:  2003-04       Impact factor: 25.083

2.  [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].

Authors:  H Ding; Y Chen; X Feng; D Liu; A Wu; L Zhang
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2001-04

3.  Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrix.

Authors:  V Paradis; P Mathurin; V Ratziu; T Poynard; P Bedossa
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

4.  ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis.

Authors:  Min Zheng; Wei-Min Cai; Hong-Lei Weng; Rong-Hua Liu
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Low plasma apolipoprotein A-I level: new prognostic criterion in childhood cirrhosis?

Authors:  M A Selimoğlu; S Aydoğdu; R V Yağci
Journal:  Turk J Pediatr       Date:  2001 Oct-Dec       Impact factor: 0.552

6.  Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer.

Authors:  Z Chen; A Keech; R Collins; B Slavin; J Chen; T C Campbell; R Peto
Journal:  BMJ       Date:  1993-04-03

7.  Role of liver extracellular matrix in transcriptional and post-transcriptional regulation of apolipoprotein A-I by hepatocytes.

Authors:  V Paradis; A Laurent; P Mathurin; T Poynard; D Vidaud; M Vidaud; P Bedossa
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1996-06       Impact factor: 1.770

8.  Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute viral hepatitis and chronic liver disease.

Authors:  C Vergani; G Trovato; A Delù; M Pietrogrande; N Dioguardi
Journal:  J Clin Pathol       Date:  1978-08       Impact factor: 3.411

9.  Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells.

Authors:  Pamela A Norton; Qiaoke Gong; Anand S Mehta; Xuanyong Lu; Timothy M Block
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

10.  Prothrombin index decrease: a useful and reliable marker of extensive fibrosis?

Authors:  Jean-Francois Cadranel; Philippe Mathurin
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-10       Impact factor: 2.566

View more
  1 in total

1.  Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis.

Authors:  Dariusz Marek Lebensztejn; Elzbieta Skiba; Jolanta Tobolczyk; Maria Elzbieta Sobaniec-Lotowska; Maciej Kaczmarski
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.